Eleven patients with coronary artery disease and chronic heart failure were studied before and three months after the angiotensin converting enzyme inhibitor enalapril was added to their frusemide medication. The following were measured: left ventricular pressure and volume with transient occlusion of the inferior vena cava, radionuclide angiography, and hormone concentrations in plasma. As in other reported studies, the clinical condition of the patients improved and their exercise tolerance increased moderately. Addition of enalapril reduced end diastolic and systolic pressure, reduced ventricular volume, and concomitantly increased the ejection fraction. The end systolic pressure-volume relation shifted to the left as it did in a similar animal study. In the animal study unloading by a vasodilator did not induce a leftward shift, so it can be inferred that in the present study unloading combined with a decrease in the angiotensin concentration was instrumental in remodelling the heart. Though unloading was expected to have a beneficial effect on the oxygen supply/demand ratio of the heart, the
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Eleven patients with coronary artery disease and chronic heart failure were studied before and three months after the angiotensin converting enzyme inhibitor enalapril was added to their frusemide medication. The following were measured: left ventricular pressure and volume with transient occlusion of the inferior vena cava, radionuclide angiography, and hormone concentrations in plasma. As in other reported studies, the clinical condition of the patients improved and their exercise tolerance increased moderately. Addition of enalapril reduced end diastolic and systolic pressure, reduced ventricular volume, and concomitantly increased the ejection fraction. The end systolic pressure-volume relation shifted to the left as it did in a similar animal study. In the animal study unloading by a vasodilator did not induce a leftward shift, so it can be inferred that in the present study unloading combined with a decrease in the angiotensin concentration was instrumental in remodelling the heart. Though unloading was expected to have a beneficial effect on the oxygen supply/demand ratio of the heart, the patients still showed the same drop in the ejection fraction during exercise as they did before treatment with enalapril, and early diastolic filling did not improve. Normally, regression of cardiac dilatation is only found if pump function improves; the present study showed that unloading in combination with angiotensin converting enzyme inhibition reshapes the ventricle without improving intrinsic pump function. increases.4 After myocardial infarction the ventricle dilates mainly as a result of slippage of bundles of myocardial cells.5 Unloading of the heart by angiotensin converting enzyme inhibition reduces ventricular volume,' 6 7 mainly by lowering the filling pressure, but perhaps also by remodelling, because extensive postinfarct dilatation seems to be reversible. Moreover, it is clear that the observed improvement in exercise tolerance is due not only to better pump function but also to a more efficient distribution of the peripheral circulation. It is a matter of debate whether the pump function improves only because of the unloading and remodelling or because there is also some improvement in the intrinsic function of the cardiac muscle. Intracoronary injection of angiotensin converting enzyme inhibitors blocked the direct inotropic action of angiotensin II,."o but the long term effect may be to enhance muscle function by improving metabolism and allowing hypoxic muscle cells to recover their contractility.
We studied 11 patients with chronic congestive heart failure with dyspnoea class II-IV (New York Heart Association) before and after three months of treatment with enalapril added to a regimen of diuretics, salt restriction and, in some, digitalis or antiarrhythmic agents. Haemodynamic function was extensively measured. We used on line pressurevolume studies with transient occlusion of the inferior vena cava and radionuclide angiography at rest and during exercise to identify the effects of unloading, of remodelling, and of a possible improvement of myocardial function.
Patients and methods

PATIENTS
Eleven men (aged 48-66 (mean 59)) with chronic congestive heart failure caused by coronary artery disease and myocardial infarction completed the study within a period of 18 months. The patients gave their informed consent and the protocol of the study was approved by the hospital ethics committee. Eighteen patients entered the study but seven did not complete it. Three died suddenly during follow up, one underwent a coronary bypass operation, and three stopped the treatment with enalapril because of side effects.
Inclusion criteria were cardiac failure class II-IV (New York Heart Association) and a left ventricular ejection fraction <45% at rest, as measured by radionuclide angiography. Stable exercise dependent angina was not a reason for exclusion and patients with mild mitral regurgitation secondary to ventricular dilatation or papillary muscle dysfunction were also not excluded. Exclusion criteria were severe hypertension, myocardial infarction less than four months before, albuminuria, serum creatinine concentrations > 150 umol/l, and valvar or congenital heart disease.
STUDY PROTOCOL
Patients were admitted to the cardiology ward once before treatment and again after three months of treatment. During each admission an exercise test was performed with radionuclide imaging of the left ventricle, followed after one or two days by a right and left heart catheterisation with pressure-volume measurements and balloon occlusion of the inferior vena cava to determine the pressurevolume relations of the left ventricle. Blood samples were taken with appropriate precautions to measure plasma renin and angiotensin converting enzyme activity and concentrations of angiotensin II and atrial natriuretic peptide in the resting state. All prior medication was continued throughout the study and treatment with enalapril was started ( < 20 mg/day). The first dose was given after the haemodynamic tests were completed and the effects were carefully monitored. After three months all variables were measured again.
BIOCHEMICAL MEASUREMENTS
To exclude the effect of physical activity blood samples were taken at 6.00 am before the patients rose. Blood samples for the measurement of angiotensin II and angiotensin converting enzyme activity were collected separately and a combination of EDTA and phenanthroline or ofheparin and aprotinin was added, respectively. The samples were kept on ice, centrifuged in a precooled centrifuge, and stored at -70°C. Angiotensin converting enzyme activity was measured spectrophotometrically with a test kit (Paesel, Frank- furt, Germany) that had 15 U/I as its lower limit of reference range. Plasma renin activity was measured by radioimmunoassay of the angiotensin I generated from the a2 precursor under standard conditions (Baxter, Cam The exercise test was performed in combination with radionuclide imaging on a normal upright bicycle ergometer. The workload was increased stepwise from 10 W by 10 W every minute until exhaustion. A Toshiba 40A gamma camera was used to make two radionuclide scintigrams, the former in the 10 minutes immediately before exercise and the latter during the last three minutes of exercise. Red blood cells were labelled in vivo by injecting 750 MBq (20 mCi) technetium-99m. Gated radionuclide angiograms were made in the 400 left anterior oblique position with a 30°c audocranial tilt to obtain optimal separation of the right and left ventricles. The volume of the left ventricle was calculated from the number of ventricular counts and the activity of a blood sample measured simultaneously. Data were collected in a matrix of 64 x 64 pixels.
HAEMODYNAMIC MEASUREMENTS A 7 F thermodilution Swan-Ganz flow directed catheter was introduced into a femoral vein and its tip was floated into a branch of a pulmonary artery. It was used to measure pressures and cardiac output (by thermodilution and the Fick method). An To obtain pressure-volume loops under changing loading conditions a balloon catheter (Meditech, Watertown, Massachusetts, USA) was introduced percutaneously into the femoral vein and the balloon was positioned in the inferior vena cava. When the balloon was inflated with carbon dioxide the venous return to the heart was reduced sufficiently to allow the end systolic pressure-volume relation""7 and the relation between dP/dt,. and end diastolic volume'8 to be determined. Table 2 shows the volume data obtained by radionuclide angiography. The end diastolic and end systolic volume indices of the left ventricle fell significantly. In nine patients in whom pressure-volume loops could be recorded both before and after treatment, the diastolic pressure-volume relation shifted to the left (fig 1) . The ejection fraction at rest increased slightly from 0-24 (0-09) to 0 30 (0-1 1) (p < 0 05).
REMODELLING OF THE VENTRICLE
Pressure-volume loops could be recorded in nine patients. In two (patients 2 and 5) it was not possible to position the conductance catheter in the correct position. Figure 1 shows 1  40  50  90  18  14  -4  104  85  19  9-90  2  50  100  145  20  19  -1  123  98  25  18-85  3  110  65  105  32  32  0  142  109  33  9 95  4  70  60  100  19  24  5  125  101  24  15-55  5  100  88  135  21  13  -8  189  149  40  24 30  6  110  66  100  38  31  -7  116  72  44  15-55  7  90  100  150  24  15  -9  103  78  25  24-00  8  80  112  142  12  12  0  121  107  14  18-46  9  80  82  120  42  37  -5  121  87  34  22-80  10  60  90  108  19  19  0  153  124  29  14-58  11  120  95  120  21  18  -3  135  107  28  20-40  Mean  83  83  120  24  21  -3  130  102  29 the passive diastolic properties of the ventricle had changed. This was consistently seen in all patients in whom a pressure-volume loop could be recorded. Figure 2 shows the shifts of the end diastolic volumes of the whole group. In seven patients the maximum workload increased, in two it remained unchanged, and in two it decreased after treatment (table 2) . On average the maximum exercise capacity increased slightly but not significantly. Heart rate at maximal workload remained practically the same, as did the rate-pressure product. Though eight patients felt that their exercise tolerance had improved, only four increased their maximum rate-pressure product. Three of them did so at the expense of a considerable drop of the ejection fraction during exercise, more than observed before treatment; in the fourth patient the ejection fraction was not measured after treatment.
INDICES OF CONTRACTILITY
On average the values of dP/dt. were below normal before (987 (300) mm Hg/s) and remained unchanged after treatment (988 (337) -,--mm Hg/s). The inferior vena cava could be 300 obstructed effectively in only four patients; in the other five patients in whom pressurevolume loops were recorded the inflation of the balloon did not reduce diastolic pressure and volume either before or after treatment. Figure   3 shows the typical almost parallel shift to the left of the end systolic pressure-volume relation, which indicated almost unchanged end systolic pressure-volume relation. The mean volume intercept shifted from 128 (65) to 55 (24) ml and the slope remained practically the same (0 34 (0.22) mm Hg/ml before and 0-28 (0-10) mm Hg/ml after treatment). The slope of the relation between dP/dt,,,, and end diastolic volume also remained practically unchanged- absence of a rise a as a sign of highc or hypoxic suppi by a limited coroi the mean ejecti decreased from 0 at maximum wor remained uncha from 0-19 to 0 2 ejection fraction nine patients, re was measured or average, the eje( dropped from 0 3 maximum workl in the ejection fr. at maximum workload is taken Unloading the heart with a predominantly er overt myocardial ischaemia arterial vasodilator, hydralazine, did not ression of contractility caused produce such an effect.' From this it can be nary reserve. Before treatment inferred that the ventricle is reshaped only ion fraction for the group because unloading is combined with a reduc--24 (0-09) at rest to 0-21 (0-08) tion of the angiotensin concentration. This kload; it fell in seven patients, conditional role of a reduction of angiotensin is nged in three, and increased supported by the results of experimental 4 in one. After treatment the studies that point to a crucial role of such decreased during exercise in reduction in changing the collagen structure of mained constant in one, and the heart. A comparison ofthe effects ofdifferent nly at rest in one patient. On types of hypertension and of angiotensin conction fraction after treatment verting enzyme inhibition on rat hearts showed 30 (0-11) at rest to 0-22 (0-12) at that renovascular hypertension induced caroad. In seven patients the fall diac hypertrophy with a higher collagen conaction during exercise became tent than low renin hypertension caused by infrarenal banding.23 Regression of hypertrophy with angiotensin converting enzyme inhibition is accompanied not only by a reduction of collagen content but also by a considerable change in the ratio of type I and type III collagen.2425
Because the support structures in the heart were reshaped, the collagen tethers between bundles of cardiac fibres must first have been dissolved and later reformed.26 Acute unloading shifts the diastolic pressure-volume relation only slightly to the left,'5 but in combination with the reconstruction of collagen tethers such a shift to a lower volume can be repeated until an appreciably lower volume is reached. This implies that remodelling of the heart will occur only if the heart is unloaded while the plasma concentrations of angiotensin II are simultaneously reduced. In an experimental study, treatment with a vasodilator that unloads the heart but activates the reninangiotensin-aldosterone system did not reduce heart size.'
In the acute experiment a leftward shift of the end systolic pressure-volume relation is usually interpreted as a sign of improved contractility.52728 The same is true for the relation between dP/dt,., and end diastolic volume,'827 but is such interpretation still correct in a long term study in which the ventricle is considerably remodelled and reduced in size? We found no additional evidence of an improvement of intrinsic contractile function in this study. A direct positive effect of enalapril would have been unlikely, because angiotensin II was weakly inotropic in isolated cardiac muscle"'0 and angiotensin converting enzyme inhibitors had a weakly negative inotropic action.29 Contractile function might have improved, however, by improvement in the heart's metabolism. Coronary reserve is usually reduced in cardiac failure and regional hypoxia of the muscle may add to the problem of cardiac failure caused by previous infarctions. The unloading of the heart may have a beneficial effect on its metabolism by reducing oxygen consumption, but lowering coronary perfusion pressure may have an opposite effect. The present data on reduction of ejection fraction during exercise suggest that the net effect of the unloading treatment on the oxygen balance was negligible or in some patients even slightly negative. Nor did the data on ventricular relaxation indicate an improvement in cardiac metabolism. So there seems little reason to suppose that treatment with an angiotensin converting enzyme inhibitor in this group of patients improved intrinsic muscle function, despite the leftward shift of end systolic pressure-volume relation and the relation between dP/dt. and end diastolic volume. The improvement of pump function seems to be solely the result of the remodelling of the heart, without recruitment of hitherto hypoxic fibres.
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